NR AGSB
AU Korn,K.; Fleckenstein,B.
TI [Viruses and cell therapy. Evaluation of cell therapy from the virologic viewpoint]
OT Viren und Zellulartherapie. Bewertung als Zellulartherapie aus virologischer Sicht.
QU Fortschritte der Medizin 1994 Jun 30; 112(18): 257-60
PT journal article; review; review, tutorial
AB The risks of cell therapy as seen by the microbiologist and virologist, are not calculable. Numerous viruses with longterm persistence in the host cells, cannot be detected on the basis of an acute disease in the host. This applies, for example to herpesviruses, lentiviruses, retroviruses, hepatitis C virus, Borna disease virus and the so-called unconventional viruses. There are two reasons why testing of the donor animal ist not possible, the first being the great number of potential pathogens, the second being the fact that for some of these agents there are no signs of a diagnostic approach involving isolation or antibody detection. e.g. scrapie (BSE). Further, so far unknown viruses must be expected.
ZR 12
MH Animal; *Complementary Therapies; English Abstract; Human; Risk Factors; Tissue Therapy/adverse effects/*methods; Virus Diseases/*transmission; Virus Latency
AD Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg.
SP deutsch
PO Deutschland